The Latest Breaking News from FDA

US will stretch monkeypox vaccine supply with smaller doses

U.S. health officials are endorsing a new monkeypox vaccination strategy designed to stretch limited supplies by allowing health professionals to vaccinate up to five people — instead of one — with each vial

The Independent UK · Aug 9, 2022

Dow Drops Over 100 Points; Verona Pharma Shares Jump

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.

Benzinga · Aug 9, 2022

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

Benzinga · Aug 9, 2022

Recap of Monday's Biotech Catalysts - End Of the Day Summary

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

Benzinga · Aug 8, 2022

FDA Can't Stop Harassing Distillers Who Made Hand Sanitizer During the Pandemic

After 18 months of dealing with the FDA, some distillers are regretting making hand sanitizers at all.

Reason · Aug 8, 2022

Plan to axe 91,000 civil servants ‘only possible with cuts to services’

Review casts doubt on Boris Johnson’s claim that frontline services would not be harmed

The Guardian - UK · Aug 8, 2022

LEXX: Put Your Drinks Up! Four Deals Signed in June

By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT

Benzinga · Aug 8, 2022

Nature's secret drug stockpile

Some scientists are looking for new drugs in nature rather than synthesizing them in the lab. Here's why

Salon · Aug 7, 2022

In fight against monkeypox, government isn’t learning from past experience

The Biden administration’s response has made key mistakes in handling the emerging threat. We hope this situation serves as a wake-up call to rethink and re-tool emergency response policies and practices.

Chicago Sun-Times · Aug 6, 2022

FDA considering "dose-sparing" approach to increase availability of Jynneos vaccine

Health care providers could use one vial of the vaccine to administer up to five doses without an impact on safety or efficacy.

Axios · Aug 5, 2022